These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32690659)

  • 1. E3 Ubiquitin Ligase Von Hippel-Lindau Protein Promotes Th17 Differentiation.
    Chitrakar A; Budda SA; Henderson JG; Axtell RC; Zenewicz LA
    J Immunol; 2020 Aug; 205(4):1009-1023. PubMed ID: 32690659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the C-terminal alpha-helical domain of the von Hippel-Lindau protein in its E3 ubiquitin ligase activity.
    Lewis MD; Roberts BJ
    Oncogene; 2004 Mar; 23(13):2315-23. PubMed ID: 14691445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1α interaction.
    Buckley DL; Van Molle I; Gareiss PC; Tae HS; Michel J; Noblin DJ; Jorgensen WL; Ciulli A; Crews CM
    J Am Chem Soc; 2012 Mar; 134(10):4465-8. PubMed ID: 22369643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E3 ligase VHL promotes follicular helper T cell differentiation via glycolytic-epigenetic control.
    Zhu Y; Zhao Y; Zou L; Zhang D; Aki D; Liu YC
    J Exp Med; 2019 Jul; 216(7):1664-1681. PubMed ID: 31123085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipase D2 promotes degradation of hypoxia-inducible factor-1α independent of lipase activity.
    Park MH; Bae SS; Choi KY; Min do S
    Exp Mol Med; 2015 Nov; 47(11):e196. PubMed ID: 26611735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor α is a novel target of the Von Hippel-Lindau protein and is responsible for the proliferation of VHL-deficient cells under hypoxic conditions.
    Jung YS; Lee SJ; Yoon MH; Ha NC; Park BJ
    Cell Cycle; 2012 Dec; 11(23):4462-73. PubMed ID: 23159849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation.
    Cho JJ; Xu Z; Parthasarathy U; Drashansky TT; Helm EY; Zuniga AN; Lorentsen KJ; Mansouri S; Cho JY; Edelmann MJ; Duong DM; Gehring T; Seeholzer T; Krappmann D; Uddin MN; Califano D; Wang RL; Jin L; Li H; Lv D; Zhou D; Zhou L; Avram D
    Nat Commun; 2019 Feb; 10(1):701. PubMed ID: 30741923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iASPP is essential for HIF-1α stabilization to promote angiogenesis and glycolysis via attenuating VHL-mediated protein degradation.
    Zhao D; Zheng S; Wang X; Liu H; Zhao K; Li L; Hu Y
    Oncogene; 2022 Mar; 41(13):1944-1958. PubMed ID: 35169254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity.
    Lee JH; Elly C; Park Y; Liu YC
    Immunity; 2015 Jun; 42(6):1062-74. PubMed ID: 26084024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of HIF-1 and ubiquitin in conventional renal cell carcinoma: relationship to mutations of the von Hippel-Lindau tumor suppressor gene.
    Hughson MD; He Z; Liu S; Coleman J; Shingleton WB
    Cancer Genet Cytogenet; 2003 Jun; 143(2):145-53. PubMed ID: 12781449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leu-574 of HIF-1alpha is essential for the von Hippel-Lindau (VHL)-mediated degradation pathway.
    Huang LE; Pete EA; Schau M; Milligan J; Gu J
    J Biol Chem; 2002 Nov; 277(44):41750-5. PubMed ID: 12205091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Hippel-Lindau (VHL) small-molecule inhibitor binding increases stability and intracellular levels of VHL protein.
    Frost J; Rocha S; Ciulli A
    J Biol Chem; 2021 Aug; 297(2):100910. PubMed ID: 34174286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of SOCS and VHL Proteins in Neuronal Differentiation and Development.
    Kanno H; Matsumoto S; Yoshizumi T; Nakahara K; Kubo A; Murata H; Shuin T; U HS
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1alpha mediated transcription.
    Ampofo E; Kietzmann T; Zimmer A; Jakupovic M; Montenarh M; Götz C
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1729-35. PubMed ID: 20637892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Hippel-Lindau Acts as a Metabolic Switch Controlling Nephron Progenitor Differentiation.
    Cargill K; Hemker SL; Clugston A; Murali A; Mukherjee E; Liu J; Bushnell D; Bodnar AJ; Saifudeen Z; Ho J; Bates CM; Kostka D; Goetzman ES; Sims-Lucas S
    J Am Soc Nephrol; 2019 Jul; 30(7):1192-1205. PubMed ID: 31142573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor α.
    Okumura F; Uematsu K; Byrne SD; Hirano M; Joo-Okumura A; Nishikimi A; Shuin T; Fukui Y; Nakatsukasa K; Kamura T
    Mol Cell Biol; 2016 Jun; 36(12):1803-17. PubMed ID: 27090638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP9X destabilizes pVHL and promotes cell proliferation.
    Zhang C; Peng Z; Zhu M; Wang P; Du X; Li X; Liu Y; Jin Y; McNutt MA; Yin Y
    Oncotarget; 2016 Sep; 7(37):60519-60534. PubMed ID: 27517496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.